Background. -Studies on the association between family history of cardiovascular disease and arterial stiffness are rare. Aims. -This study evaluated the possible relationship between family history of cardiovascular disease and arterial stiffness in the Japanese population, by measuring brachial-ankle pulse wave velocity (ba-PWV).
Background
Cardiovascular events are major causes of death worldwide. Atherosclerosis is the main factor leading to cardiovascular events. Arterial stiffness is an indicator of atherosclerotic vascular change and can be assessed by measuring pulse wave velocity (PWV) [1] . Many epidemiological studies have reported positive associations between PWV and the development of atherosclerotic disease [2, 3] . PWV is recognized as a marker of the severity of vascular damage [4] ; moreover, it is a predictor of cardiovascular events [5] and mortality [6] . Brachial-ankle PWV (ba-PWV) can be measured conveniently and non-invasively, and is useful for evaluating the early stages of atherosclerosis [7, 8] .
Mortality due to ischaemic heart disease is less frequent in Japan than in Western countries [9] . However, mortality and morbidity due to stroke are more frequent in Japan, especially in men [9] . Recent studies have revealed that increased PWV is associated with coronary and cerebral atherosclerosis [10, 11] . Family history is a risk factor for many chronic diseases, including hypertension, ischaemic heart disease and stroke [12, 13] . However, little is known about the influence of family history of cardiovascular disease on arterial stiffness. Therefore, this study evaluated the possible relationship between a family history of ischaemic heart disease, stroke or hypertension and arterial stiffness in the Japanese population.
Methods

Study subjects
A total of 1065 participants aged 35-69 years, who were enrolled in the baseline survey of a prospective cohort study in Tokushima Prefecture (Japan), and who underwent measurement of ba-PWV and serum lipid concentration at the baseline survey from November 2009 to June 2012 were included in this cross-sectional study. This cohort study was performed as part of the prospective cohort study (the Japan Multi-Institutional Collaborative Cohort [J-MICC] Study), as described previously [14] . Briefly, the aim of the J-MICC Study is to examine the associations of lifestyle and genetic factors and their interactions with lifestyle-related diseases. All participants in the J-MICC Study provided written informed consent. The ethics committees of the Nagoya university school of medicine (the affiliation of the former principal investigator [Nobuyuki Hamajima]), the Aichi cancer centre (the affiliation of the current principal investigator [Hideo Tanaka]) and the university of Tokushima graduate school approved the protocol of this study.
Questionnaire
We obtained information on individual lifestyle characteristics for the past year through a structural self-administered questionnaire; all the responses were reviewed by trained staff at the time of the survey. Leisure-time exercise was estimated based on the International Physical Activity Questionnaire [15] . Exercise was divided into three levels: light exercise, such as walking or hiking; moderate exercise, such as light jogging or swimming; and vigorous exercise, such as marathon running or competitive sports. Degrees of leisure-time exercise for the three levels were expressed as metabolic equivalent of task (MET)-hours/week (MET level × hours of activity × events per week) and summed [16] . In this estimation, 3.4 METs were assigned for light exercise, 7.0 METs for moderate exercise and 10.0 METs for vigorous exercise. Body height was obtained from the questionnaire; body weight was measured to the nearest 0.1 kg at the survey. Body mass index was calculated as weight (in kilograms) divided by height (in meters) squared. Additionally, we obtained information regarding first-degree family histories of ischaemic heart disease, including myocardial infarction or angina pectoris, stroke and hypertension (i.e. positive, negative or unknown). When analysed, a response of 'positive' was regarded as having a family history of the disease, whereas 'negative' and 'unknown' were regarded as not having a family history of the disease.
Pulse wave velocity and biochemical measurements
ba-PWV was measured using a waveform analyser (model BP-203RPE III; Colin, Co. Ltd., Komaki, Japan), as described previously [17] . Briefly, the subjects were examined while resting in the supine position in an air-conditioned room. Extremity blood pressure was measured using an oscillometric method and the ankle-brachial pressure index (ABI) was automatically calculated. Heart rate was recorded simultaneously. ba-PWV was calculated using time-phase analysis between the right brachial artery pressure and volume waveforms at both ankles. To reduce interobserver variation, all ba-PWV measurements were performed by one researcher throughout the study. Individual ba-PWV and ABI data are expressed as the mean of the bilateral ba-PWV and ABI, respectively. Venous blood was aspirated from each participant and serum was separated within 3 hours. Serum lipid concentrations were measured at an external laboratory (BML Inc., Tokyo, Japan).
Statistical analyses
Among the 1065 participants (710 men and 355 women) initially included in this cross-sectional study, we excluded 34 with a history of ischaemic heart disease (n = 21) and stroke (n = 16). We excluded another five subjects who had a low right or left ABI (ABI ≤ 0.9), which suggested that they might have had peripheral arterial occlusive disease. There were no subjects who self-reported a history of cirrhosis or hepatic cancer. We further excluded subjects with missing data on family history of cardiovascular diseases (n = 10). After excluding an additional 12 subjects for whom serum lipid concentration data were missing, 1004 subjects (664 men and 340 women) were finally included in the analyses.
Continuous variables are expressed as mean ± standard deviation or median (25 percentile, 75 percentile). Categorical variables are expressed as proportion (%). Student's t test, Wilcoxon rank-sum test and Fisher's exact test were used to compare baseline characteristics between subjects with and without a family history of diseases.
Prevalent hypertension was defined as systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg or receiving antihypertensive treatment. Hypercholesterolaemia was defined as serum total cholesterol ≥ 220 mg/dL or receiving treatment for hypercholesterolaemia, and low high-density lipoprotein (HDL) cholesterol was defined as serum HDL cholesterol < 40 mg/dL. Elevated triglycerides were defined as serum triglycerides ≥ 150 mg/dL. Prevalent diabetes was defined as having a history of diabetes. We used general linear models to evaluate the associations of family histories of ischaemic heart disease, stroke or hypertension with ba-PWV values in men and women separately, after adjusting for the probable covariates. Adjusted covariates were as follows: age (continuous) (model 1); age and systolic blood pressure (< 120, 120 to < 140, 140 to < 160, ≥ 160 mmHg without treatment and receiving antihypertensive treatment) (model 2); age, systolic blood pressure, body mass index (kg/m 2 ) (sex-specific quartiles), smoking status (current, past and never), alcohol drinking (current, past and never), leisure-time exercise (MET hours/week) (sexspecific quartiles), hypercholesterolaemia (no/yes), low HDL cholesterol (no/yes), elevated triglycerides (no/yes), diabetes (no/yes) and heart rate (continuous), with experienced menopause (no/yes) included for women (model 3).
We further evaluated the associations of family histories of ischaemic heart disease, stroke or hypertension with ba-PWV values in additional models; family histories of these diseases were inserted simultaneously into the models, to avoid their overlapping influences, adjusting for age (model 4), age and systolic blood pressure (model 5) and the same covariates as in model 3 (model 6).
All statistical tests were based on two-sided probabilities performed using SAS version 8.2 (SAS Institute Inc., Cary, NC, USA). The level of statistical significant was set at P < 0.05.
Results
Baseline characteristics
Age was significantly correlated with ba-PWV in both sexes (r = 0.492, P < 0.001 in men and r = 0.534, P < 0.001 in women). Systolic blood pressure was also strongly correlated with ba-PWV in both sexes (r = 0.646, P < 0.001 in men and r = 0.770, P < 0.001 in women). There were no significant differences between sexes in the proportions with family histories of ischaemic heart disease, stroke or hypertension (data not shown). Tables 1 and 2 show the characteristics of the subjects with and without family histories of ischaemic heart disease, stroke or hypertension in men and women, respectively. Men had considerably higher ba-PWV values than women. Subjects of both sexes with a family history of ischaemic heart disease or stroke were older than those without such a family history. Subjects of both sexes with a family history of stroke or hypertension had significantly higher systolic blood pressure and higher prevalence of hypertension than those without such a family history, while those with a family history of ischaemic heart disease did not. Subjects of both sexes with a family history of stroke or hypertension showed significantly higher ba-PWV values than those without such a family history. Women with a family history of ischaemic heart disease had significantly higher ba-PWV values than those without that trait, while men with a family history of ischaemic heart disease did not.
Association between family history of cardiovascular disease and arterial stiffness
Sex-specific analyses (Table 3) revealed that subjects of both sexes with a family history of stroke had significantly higher age-adjusted, age and systolic blood pressure-adjusted and multivariable-adjusted means of ba-PWVs than those without such a family history (models 1, 2 and 3), while subjects of both sexes with a family history of ischaemic heart disease did not. Subjects of both sexes with a family history of hypertension showed significantly higher age-adjusted means of ba-PWVs than those without that trait (model 1), although these differences disappeared in age and systolic blood pressure-adjusted and multivariable-adjusted models (models 2 and 3). These results did not substantially alter when family histories of these diseases were inserted simultaneously into the same models (models 4, 5 and 6) ( Table 4) .
Discussion
In this study, we investigated that having a family history of stroke was potentially associated with increased ba-PWV in Japanese men and women, independent of other wellknown atherosclerotic risk factors including hypertensive elements.
Carotid-femoral PWV (cf-PWV) is an established index for assessing aortic stiffness; its values are well correlated with vascular damage [4] . However, measuring cf-PWV is rather complicated and time consuming. Meanwhile, ba-PWV measurement is convenient and only requires a short time. The ba-PWV reflects the arterial stiffness of both large and mid-sized arteries such as the aorta and arteries of the lower limbs [7, 17] ; however, it is well correlated with cf-PWV as well as aortic PWV assessed using a direct catheter method [7] . Therefore, ba-PWV measurement is useful for screening arterial atherosclerotic changes in large populations. Aging was strongly associated with increased ba-PWV in both sexes, which is concordant with previous studies [17] . Furthermore, ba-PWV was higher in men than in women, which is consistent with other reports [17, 18] . Some studies have demonstrated that oestrogen has protective effects against increased arterial stiffness [19] .
Cohort studies have revealed that increased PWV is associated with an increased incidence of stroke in the general population after adjusting for other known cardiovascular risk factors [20, 21] . In addition, increased arterial stiffness may predict cerebrovascular events through an increased central brachial pulse pressure [22] . According to these reports, there should be a close association between stroke, which has familial inheritance, and increased ba-PWV. However, studies on the impact of family history of stroke on ba-PWV are rare. Moreover, mortality and morbidity due to stroke are frequent in Japan, especially in men [9] . Therefore, we evaluated the relationship between family history of stroke, ischaemic heart disease or hypertension and arterial stiffness in the Japanese population. In addition to age and sex, blood pressure is a well-recognized determinant of ba-PWV [23] . In this study, we confirmed that systolic blood pressure is strongly correlated with ba-PWV in both sexes (r = 0.646, P < 0.001 in men and r = 0.770, P < 0.001 in women). Increased blood pressure and arterial stiffness may be associated with each other. Age-adjusted associations were found between a family history of hypertension and increased ba-PWV in both sexes, although these associations disappeared after further adjustment for systolic blood pressure and multivariable covariates, including blood pressure. The findings suggest that hypertensive elements may largely contribute to the relationship between a family history of hypertension and increased ba-PWV. By contrast, we observed the age-adjusted, age and systolic blood pressure-adjusted and multivariable-adjusted associations between a family history of stroke and increased ba-PWV in both sexes; these adjusted associations did not substantially alter when family histories of ischaemic heart disease, stroke or hypertension were inserted simultaneously into the same models. Therefore, a family history of stroke itself may contribute considerably to an increased ba-PWV, independent of other well-known atherosclerotic risk factors, including hypertensive elements, in both sexes. Conventional cardiovascular risk factors, such as hypertension, Data are mean ± standard deviation, % or median (25th percentile, 75th percentile). ABI: ankle-brachial pressure index; ba-PWV: brachial-ankle pulse wave velocity; BP: blood pressure; HDL: high-density lipoprotein; MET: metabolic equivalent of task. smoking, hyperlipidaemia, diabetes and atrial fibrillation, are not able to account for all stroke risk [24] . Epidemiological studies, including twin studies and family history studies, suggest that genetic predisposition is also important for stroke risk [25, 26] . A number of genes contributing to stroke have been discovered by linkage, the candidate-gene approach and genome-wide association studies. Therefore, genetic predisposition is thought to be one mediator for the association between a family history of stroke and increased arterial stiffness. Shared familial lifestyle is another probable mediator for this association; however, it is difficult to separate this from genetic risk. Family history studies have shown that genetic risk of stroke may be stronger for the large-artery disease and small-vessel disease subtypes [27] ; the small-vessel disease subtype (lacunar stroke) is common in Japanese. In fact, a PRKCH (protein kinase C eta) variant has been identified as being associated with the small-vessel disease stroke subtype in a Japanese population [28] . For a Japanese individual with a family history of stroke, genetic predisposition may contribute to increased arterial stiffness rather than shared familial lifestyle.
In the current study, we could not find an association between a family history of ischaemic heart disease and ba-PWV. There are few reports on the relationship between family history of ischaemic heart disease and ba-PWV. A previous report suggested that there was no association between aortic PWV and a family history of myocardial infarction in asymptomatic middle-aged women [29] , and this finding is concordant with our result. Given that acute myocardial infarction is a weak reflection of atherosclerotic vascular disease, we might not find an association between a family history of ischaemic heart disease and ba-PWV.
Study limitations
Our study has several limitations. First, information about age at time of first episode and subtypes of stroke recorded in family histories of diseases was lacking; therefore, we could not evaluate the specific association between age at first episode or subtypes of stroke in family histories and increased ba-PWV. Second, information about the family history of diseases was self-reported; therefore, unrecognized cases may have existed. However, because ischaemic heart disease and stroke events are symptomatic, there may only have been a few unrecognized cases of these events. In addition, misclassified self-reported information might attenuate the true effects. Third, our study included relatively few subjects, possibly lowering the statistical power. Finally, as all of our subjects were Japanese, our results may not be applicable to other ethnic populations.
Conclusions
Our study demonstrates that a family history of stroke is potentially associated with increased ba-PWV, independent of other well-known atherosclerotic risk factors, including hypertensive elements, in both sexes in the Japanese population. Further large studies, including detailed information about age at first episode and subtypes of stroke in family histories, will be needed.
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